ReportWire

Tag: autism spectrum disorder

  • CDC replaces website on vaccines and autism with false and misleading statements

    [ad_1]

    The national Centers for Disease Control and Prevention have altered their website on autism and vaccines, removing unequivocal statements that immunizations don’t cause the neurodevelopmental disorder and replacing them with inaccurate and misleading information about the links between the shots and autism.

    Until Wednesday, the CDC page, “Autism and Vaccines,” began: “Studies have shown that there is no link between receiving vaccines and developing autism spectrum disorder (ASD).”

    This was followed, in large font, by the blunt statement: “Vaccines do not cause autism.”

    The rest of the page summarized some of the CDC’s own studies into autism and vaccine ingredients, none of which found any causal links between the two.

    On Wednesday, the page was altered so that it now begins: “The claim ‘vaccines do not cause autism’ is not an evidence-based claim because studies have not ruled out the possibility that infant vaccines cause autism.”

    The words “Vaccines do not cause autism” still appear near the top, but with an asterisk that leads to a note at the bottom.

    “The header ‘Vaccines do not cause autism’ has not been removed due to an agreement with the chair of the U.S. Senate Health, Education, Labor, and Pensions Committee that it would remain on the CDC website,” the site states.

    The chair of that committee, Sen. Bill Cassidy (R-La.), cast the deciding vote to advance Robert F. Kennedy Jr.’s appointment as Health and Human Services secretary, in exchange for Kennedy’s promise that he wouldn’t erode public confidence in vaccines.

    “Studies supporting a link have been ignored by health authorities,” HHS spokesman Andrew Dixon said in an email. “We are updating the CDC’s website to reflect gold standard, evidence-based science.”

    The news was met with outrage by scientists and advocates.

    “We are appalled to find that the content on the CDC webpage ‘Autism and Vaccines’ has been changed and distorted, and is now filled with anti-vaccine rhetoric and outright lies about vaccines and autism,” the nonprofit Autism Science Foundation said in a statement. “The CDC’s previous science and evidence-based website has been replaced with misinformation and now actually contradicts the best available science.”

    The current CDC page now says the rise in autism diagnoses correlates with an increase in the number of vaccines given to infants. Multiple researchers have argued that the rise in autism spectrum disorder diagnoses is better explained by an expanding diagnostic definition of the disorder, along with better monitoring and diagnosis for more children.

    Cassidy’s office did not immediately respond to requests for comment Thursday.

    [ad_2]

    Corinne Purtill

    Source link

  • Indiana Parole Board rejects death row inmate Roy Ward’s clemency bid ahead of Oct. 10 execution

    [ad_1]

    Convicted murderer Roy Lee Ward is scheduled to be executed at the Indiana State Prison before sunrise Oct. 10. (Mugshot from the Indiana Department of Correction)

    The Indiana Parole Board on Wednesday recommended against granting clemency to death row prisoner Roy Ward, setting up a final decision by Gov. Mike Braun about two weeks before Ward’s scheduled Oct. 10 execution.

    The five-member panel deliberated behind closed doors and released its recommendation letter to the governor outlining its reasoning. Board members cited the “brutal nature” of Ward’s 2001 rape and murder of 15-year-old Stacy Payne, emphasizing that Payne was conscious during the attack and her “final hours living with the injuries that Roy Lee Ward inflicted on her.”

    “Candidly, this Board reviews thousands of cases a year, many with gruesome facts, but the victimization of Stacy Payne stood out to us,” wrote parole board chairperson Gwen Horth.

    The board’s decision is advisory. State law gives the governor sole authority to decide whether to accept the recommendation and commute Ward’s sentence, grant a reprieve or allow the execution to proceed.

    Braun has yet to announce his verdict.

    Unless the governor intervenes, Ward will be the third person executed since Indiana resumed capital punishment in December 2024, after more than a decade-long pause. Braun denied clemency for another death row inmate, Benjamin Ritchie, earlier this year.

    Story continues below.

    Roy Ward Recommendation

     

    Ward declined to appear before the board. In a written affidavit, he said his autism spectrum disorder diagnosis complicates his ability to communicate, and that he wanted to “avoid any misinterpretation” of his remorse.

    Instead, his defense team argued before the board on Monday that his life should be spared. Lawyers pointed to evidence that Ward “has been consistently remorseful” and asked the board to consider his autism diagnosis as a mitigating factor.

    The board acknowledged the legal counsel’s argument that Ward was misdiagnosed with antisocial personality disorder during trial, and that autism spectrum disorder would have better explained his behavior. Defense counsel emphasized that those with antisocial personality disorder do not feel remorse, whereas individuals with autism can — and they recounted instances of Ward expressing remorse.

    But the board wrote that it gave “little weight” to either diagnosis, concluding that the jury’s findings were supported by the facts and that the preferred autism diagnosis “still does not provide the Board with any information into why this crime occurred.”

    The panel also noted that because Ward declined to appear, they were unable to question him directly, as they often do in clemency proceedings. Without that interview, members said they could not gain additional insight into what led to the crime or whether Ward’s remorse reflected genuine rehabilitation.

    The state — along with members of Payne’s family and community — urged the board to deny clemency, telling the panel that Ward “deserves no mercy,” and that sparing him would deny Payne’s family the justice they’ve long awaited.

    DOC obtains more pentobarbital

    The clemency recommendation was handed down less than a day after newly filed court records disclosed significant details about Indiana’s execution drug stockpile. 

    In pending federal litigation brought by Ward, the Indiana Attorney General’s office confirmed Tuesday that the Department of Correction has obtained “three sets” of pentobarbital.

    Indiana State Prison Warden Ron Neal said in a sworn declaration submitted to the Northern District judge that two of those sets will expire at the end of October — after Ward’s scheduled execution on Oct. 10 — and the third set expires in March 2026.

    As of late August, Braun said the DOC didn’t yet have the necessary execution drugs, but the state would purchase more pentobarbital when necessary.

    Story continues below.

    show_temp.pl

     

    The governor previously disclosed that state officials spent $1.175 million on lethal injection doses over the past year — $600,000 of which was spent by former Gov. Eric Holcomb’s administration on drugs that expired before use. The cost has been between $275,000 and $300,000 per dose.

    State officials have not responded to the Indiana Capital Chronicle’s questions about the amount paid for the latest three doses or if any of those are expected to expire before use.

    The filings by the attorney general’s office were in response to Ward’s arguments that Indiana’s current protocol creates a constitutionally unacceptable risk of pain and suffering, in violation of the Eighth Amendment.

    The inmate’s legal team continues to challenge the use of the drug, citing evidence that pentobarbital can cause flash pulmonary edema and sensations of drowning. 

    They point to Ritchie’s execution in May, when witnesses reportedly saw the inmate “lurch upward, as if to sit up, in a spasm” after the injection, a reaction they say is “inconsistent with the normal effects of unadulterated pentobarbital.”

    More execution drug details

    For more than a year, the state has resisted releasing details about its lethal injection drugs.

    Attorneys for Ward and other death row prisoners have argued that compounded pentobarbital degrades quickly and can lose effectiveness or become contaminated because it is mixed in small batches by compounding pharmacies rather than manufactured under conditions regulated by the U.S. Food and Drug Administration.

    But the state’s latest court filings stressed that DOC is using “manufactured injectable pentobarbital” — not a compounded version — to carry out executions. Manufactured pentobarbital is produced in sterile facilities under federal quality controls, with longer shelf lives and stricter oversight than compounded alternatives, according to court filings.

    Ward’s attorneys proposed that executions could be carried out more humanely if DOC administered a “pre-dose” of fentanyl or another opioid before pentobarbital, but Neal said in his declaration that the department “does not intend to use fentanyl as part of carrying out the death sentence” and that it is not included in the prison’s directives.

    Ward also suggested firing squad or nitrogen hypoxia as alternative methods, but the state rejected those options. Currently, Indiana law only permits executions to be carried out via lethal injection.

    Public records also outline how DOC previously destroyed expired doses. 

    A “DEA Form 41,” used for documenting the destruction of controlled substances, revealed that pentobarbital was “burned” at the Putnamville Correctional Facility on June 6. Another record shows two doses of pentobarbital were destroyed on July 10 at the Indiana State Prison by “pour(ing)” them into “kitty litter.”

    It remains unclear where the execution drugs are sourced from, however. State law still protects the identity of suppliers.

    Indiana Code prohibits disclosure of “the supplier’s identity through discovery or as evidence in any civil or criminal proceeding” and exempts suppliers from oversight by the pharmacy and medical licensing boards.

    State law also does not provide access for journalists to witness executions unless invited by the condemned person. A federal lawsuit challenging that restriction is still pending. Indiana Capital Chronicle is a plaintiff in the case.

    SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX

    [ad_2]

    Source link

  • Exploring the Potential of Psychedelics for Autism 

    Exploring the Potential of Psychedelics for Autism 

    [ad_1]

    Mary Ekundayo

    Posted by Mary Ekundayo on 03/28/2024 in Alternative Medicine

    Exploring the Potential of Psychedelics for AutismExploring the Potential of Psychedelics for Autism

    Autism Spectrum Disorder is a very serious developmental issue that affects and impairs someone’s ability to communicate and interact. Fortunately, researchers have identified that there might be a positive relationship between psychedelics and autism. 

    In order to fully understand this relationship, the Marijuana Doctors team will attempt to examine Autism Spectrum Disorder and how psychedelics can affect it. 

    What is Autism Spectrum Disorder (ASD)? 

    According to various research reports, Autism Spectrum Disorder (ASD) is a developmental disability that is caused by a difference in the brain. Autism Spectrum Disorder can either be genetic or could be caused by several unknown factors acting together. 

    Autism Spectrum Disorder can start manifesting before the age of 3, and most people with ASD often have issues communicating and interacting with people. People with ASD can either have restrictive or repetitive behaviors, and their way of life may be different from those without ASD. 

    Psychedelic Effects 

    Psychedelics belong to a drug class known as hallucinogenics. These classes of drugs have been saddled with the effect of triggering non-ordinary mental states, which can provide a change in perception, thoughts, emotions, and auditory senses. 

    The most common examples of these classes of drugs are LSD (lysergic acid diethylamide), psilocybin, and ayahuasca. A lot of research has been done regarding the use of psychedelic substances to aid personal and mental development like anxiety, depression, and post-traumatic stress disorder (PTSD), and the results have been fairly positive. 

    Psychedelics and Autism 

    Although psychedelic drugs have been used to treat personal and mental illnesses or disorders, their use in treating autism has been limited. However, researchers are trying to branch out fully into this area to extensively realize the connection and safety implications of psychedelics and their effect on autism. 

    Benefits Of Psychedelics On Autism Spectrum Disorder 

    Based on the limited data on the use of psychedelics on autism, we will be taking you through a few of the most significant benefits of psychedelics on autism. 

    It Can Help Modulate Serotonin Receptors in The Brain 

    Serotine is a neurotransmitter that actively works in regulating human emotion, mood, cognition, and other physiological functions. Psychedelics have been said to help modulate similar neurotransmitters, such as serotonin receptors, in the brain. 

    The interaction of the psychedelic with the serotonin receptors in the brain can help autistic people who have similar symptoms to those of depression, anxiety, and post-traumatic stress disorder (PTSD). 

    Neurochemical Effects 

    With the little research available on psychedelics, reports on it have shown that they tend to promote neuroplasticity. This is the ability of the brain to reorganize and form new neural connections on its own. These neural connections can explain the therapeutic feeling gotten from people who have conditions like anxiety, depression, and PTSD. 

    This will also have the potential to give this therapeutic effect to people suffering from autism. 

    It Helps Increase Brain Connectivity 

    The frequent use of psychedelics has been shown to help increase the functional connection between all of the brain regions that seem not to be strongly connected. This may help people with autism experience a more holistic and strong interconnected experience of consciousness. 

    Possible Risks and Side Effects of Psychedelics on Autism 

    Before anyone decides to use psychedelic substances to treat autism, the first thing that needs to be done is to research possible risks and side effects associated with it. 

    Here are some of the possible side effects associated with psychedelics:

    Psychological or Mental Distress 

    The use of psychedelics can alter or induce one’s emotional and mental health. The drug aims to work on these emotional experiences, and can sometimes intensify their feelings of confusion or anxiety. This might even be more dangerous for people with autism because they tend to be extremely sensitive in these areas. 

    It Can Cause a Change in Communication Patterns 

    Many people with autism already struggle with speech disorders and sometimes find it difficult to communicate effectively with others. Although one of the benefits of psychedelics on autism is to help improve communication skills, it can also be an issue. 

    Psychedelics work differently for everyone. For some, it helps with communication. For others, it can further increase their difficulty in expressing themselves.

    Increased Sensory Perception 

    The psychedelic effect works to help effectively heighten your sensory organs. This might cause a huge change in auditory and visual perception, which can be pretty overwhelming for people with autism because of their sensitivity to sensory stimuli. 

    Due to the limited research on the effects of psychedelics on autism, there’s nothing much we can offer at this point, but it is advisable to approach psychedelics with caution. Additionally, it should be under professional supervision. 

    Interactions Between Psychedelics and Other Drugs 

    As a person with autism, your first step before using psychedelic substances is to check how well they interact with the drugs that have been earlier prescribed to you by your medical professionals. 

    You must visit your doctor to be sure of how well your autism drugs and psychedelic drugs work together, as some interactions might have very negative effects. 

    The Future of Psychedelics and Autism 

    For now, we are only exposed to limited data on the research of psychedelics and how they particularly affect Autism Spectrum Disorder. However, moving forward, we are hoping that there will be more comprehensive research surrounding this topic. 

    This research will further focus on how exactly it works while monitoring their symptoms and the duration it takes to work. While this is important, making sure that these psychedelic treatments are made accessible and affordable to people suffering from autism should be of utmost importance. 

    There also needs to be proper sensitization of the public about autism. Providing information about autism, its causes, and how psychedelics have been developed to help tackle it to the public will further help healthcare professionals in their professional capacities. It can assist with how they approach people with autism spectrum disorder moving forward. 

    Final Words 

    Studies about psychedelics and their effects on autism are still in the early stages. A few reports have shown that there might just be a very positive correlation between them. However, approaching it needs a little caution. While evaluating the potential benefits, you should also take a look at the potential side effects to make sure that you’re on the right path. 

    Continuous research on this subject will be beneficial to individuals who have Autism Spectrum Disorder, and this might help improve their way of life making it easier for them to function among other people. 

    [ad_2]

    Source link

  • Autism Myths and Facts

    Autism Myths and Facts

    [ad_1]

    Autism spectrum disorder (ASD) is a developmental disability with symptoms that vary widely from person to person. Children and adults with ASD may learn, socialize, and move through the world differently. 

    While the autistic community makes up over 2% of the population, many people misunderstand the condition. Experts have been working to correct misconceptions around the disability so that we can better understand the challenges faced by people with ASD.

    Myth: Girls don’t usually get autism.

    Girls are less likely to be diagnosed with autism but it’s still common, says Catherine Lord, PhD, a clinical psychologist focused on autism at the David Geffen School of Medicine at UCLA. Boys are four times more likely to be diagnosed with ASD compared with girls. While it’s also true that girls are more likely to be misdiagnosed when they do have ASD, boys are still more likely to be born with it. 

    ASD can also run in families. “There is a genetic component,” Lord says. You’re more likely to be diagnosed with ASD if you have a sibling who has it or even a second generation relative like an aunt or cousin, for example. Children who have fathers of advanced paternal age are also more likely to be diagnosed with ASD, though the risk only goes up slightly, Lord says.

    Myth: Everyone’s experience with ASD is similar.

    Those with autism have a range of symptoms and a range of experiences. Arianna Esposito of Autism Speaks notes that the skill sets, behaviors, and challenges in those with ASD may vary widely from person to person. “Every individual’s experience with autism is different because ASD refers to a broad range of conditions,” she says.

    ASD causes differences in the brain that aren’t well understood, and the symptoms can differ markedly from person to person, Esposito says. No two people have the same life experiences because their symptoms can be so different. “If you know one person with ASD, that really means that you know just one person with the condition,” she says. 

    In 2013, autism got a name change, becoming autism spectrum disorder (ASD) in the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5). The new name was chosen to include people with varying degrees of disability.

    Myth: Most people with ASD have severe intellectual disabilities.

    No. In the U.S., most people living with ASD do not have severe intellectual disabilities and are able to function relatively normally within society, Lord says. But this isn’t true on a global scale. In countries like India where they don’t have specialized support systems and are less likely to diagnose it except in extreme cases, those with ASD almost exclusively have intellectual disabilities.

    It’s also a myth that most people on the autism spectrum have a striking skill like a photographic memory or prodigal music skills,. “It happens, but it’s quite rare,” Lord says

    Myth: Vaccines cause autism.

    No, says Esposito, there is absolutely no evidence of a connection between any vaccinations and an increased risk of ASD. 

    Myth: Something in the environment is causing more kids to get autism.

    Autism is more commonly diagnosed than it once was. According to the CDC, 1 in 44 children in the U.S. have ASD, up from 1 in 88 a decade ago. But the increase isn’t likely environmental.

    Most of the evidence points to a couple of factors, Lord says. First, the way we characterize children with autism has changed and the disability now includes a host of conditions including autism disorder, pervasive developmental disorder, and Asperger’s syndrome. More awareness surrounding the condition has also increased the likelihood of a diagnosis. These two factors are likely responsible for most of the increase.

    Myth: You can only be diagnosed as a child.

    No. In fact, more and more people are being diagnosed with autism in adulthood as our understanding of the condition improves. That’s because unlike a condition such as high blood pressure, Lord says, there’s no biological marker used to diagnose ASD. As a result, many people are misdiagnosed as children with conditions like ADHD and anxiety because doctors don’t realize that ASD is the underlying cause of their symptoms. 

    Lord also says that her research has shown that some people may hover within the realm of ASD but as they age their symptoms become more pronounced because of their life circumstances. 

    [ad_2]

    Source link

  • LearningRx Reviews Results of Personal Brain Training for Students With Autism Spectrum Disorder

    LearningRx Reviews Results of Personal Brain Training for Students With Autism Spectrum Disorder

    [ad_1]

    ​June 18 is Autistic Pride Day and LearningRx (www.LearningRx.com), the world’s largest personal brain training company, is sharing the results of students with Autism Spectrum Disorder (ASD) who went through its program.

    Unlike digital brain games, one-on-one brain training uses customized exercises and incorporates immediate feedback, intensity, and loading, among other features, to target brain skills—including attention, auditory processing, memory, logic & reasoning, processing speed and visual processing.

    “Between 2010 and 2015, 857 clients came to LearningRx with a diagnosis on the autism spectrum,” explains Chief Research & Development Officer Tanya Mitchell. “The average age was 11.9. Using the Woodcock-Johnson III – Tests of Cognitive Abilities both pre- and post-training showed significant improvements for all cognitive skills.”

    According to Mitchell, overall, the largest gains were seen in auditory processing and long-term memory, followed by logic & reasoning, working memory, and broad attention.

    The average pre-training IQ score was 92 and the average post-training IQ score was 101. The average age-equivalent gain in cognitive skill performance was 3.1 years.

    In addition to clinical data, anecdotal evidence from parents of children with ASD can help explain how personal brain training helped target and train cognitive skills.

    Matthew Evans of Chattanooga, for example, came to LearningRx with an ASD diagnosis. He was at risk of being retained for another school year and struggled with reading, memory, and comprehension issues, as well as low confidence.

    After completing a LearningRx personal brain training program, Matthew’s mom says that he started reading, having conversations with other kids, and demonstrating more confidence. When he went back for a new school year, his teachers were amazed at his progress. His mom says LearningRx took the “hard parts of autism and the things he couldn’t understand and made them bearable.” Now Matthew plans to be a veterinarian.

    Watch Matthew’s video here: http://studentshoutouts.com/2016/11/03/from-reading-struggles-to-honor-roll

    To learn more about how LearningRx personal brain training might be able to help your student with ASD, visit www.learningrx.com.

    About LearningRx

    LearningRx, headquartered in Colorado Springs, Colorado, is the largest one-on-one brain training organization in the world. With 80 Centers in the U.S., and locations in 45 countries around the globe, LearningRx has helped more than 100,000 individuals and families sharpen their cognitive skills to help them think faster, learn easier, and perform better. Their on-site programs partner every client with a personal brain trainer to keep clients engaged, accountable, and on-task—a key advantage over online-only brain exercises. Their pioneering methods have been used in clinical settings for over 35 years and have been verified as beneficial in peer-reviewed research papers and journals. To learn more about LearningRx research resultsprograms, and their 9.6 out of 10 client referral rating visit http://www.learningrx.com. 

    Source: LearningRx

    Related Media

    [ad_2]

    Source link